Skip to main content
Market intelligence
CAISector not reported

Caris Life Sciences, Inc. insider activity

In the last 90 days, 1 corporate insider purchased $501,426 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$501,426
Corporate buyers
1
Latest transaction
May 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 11, 2026Jeff L VacircaCorporate insiderOpen Market Purchase31,050$16.15$501,426